Word: gore
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...Bradley, the "unpolitician," using two Senators in his bio ad? Maybe because polls show most voters still think of him first as a former basketball player--and because he trails far behind Bush and Vice President Al Gore in "leadership" ratings...
Sometimes you can read a campaign in a single slogan. Gore's bio ad is filled with pictures of his younger days as an Army journalist in Vietnam and as a newspaper reporter, probably to erase his image as someone who was born in a blue suit with a briefcase in his hand. But listen to the end of an otherwise routine commercial on health care: "Change that works for working families." Now subject that phrase to political parsing: "Change"--I'm not Bill Clinton--"that works"--I'm not a wild-eyed liberal like Bradley--"for working families...
...turning to the contentious domestic issue of abortion is certainly not the appropriate solution. While the terms of this negotiation have finally broken the deadlock between the White House and Congress, it has drawn scathing criticism from abortion rights activists and Democratic presidential frontrunners Vice-President Al Gore '69 and former New Jersey Senator Bill Bradley. And for good reason...
What doesn't make sense is that one of Gore's senior advisers, top-tier lobbyist Peter Knight, is a hired gun for pharmaceuticals giant Schering-Plough, which is in a red-hot battle to stretch out its patent for the best-selling allergy medication Claritin beyond 2002. The New Jersey-based company paid Knight's firm $100,000 in the first half of this year alone...
Schering-Plough's effort may be dead for this year. At a Judiciary Committee panel meeting last week, held out of view in a Capitol hideaway, Senator Patrick Leahy objected to moving the bill. Knight says he is closing down his firm to spend more time on the Gore campaign. But Schering-Plough is expected to continue the battle next year. If it loses again, the company has that contingency covered too: the FDA is currently considering its new super-Claritin for market approval. Its patent wouldn't expire until...